# Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

> **NCT05863052** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Oklahoma** · enrollment: 72 (estimated)

## Conditions studied

- Immune Checkpoint Inhibitors
- Metastatic Solid Tumor
- Nonsmall Cell Lung Cancer
- Melanoma
- Renal Cell Carcinoma
- Gastrointestinal Cancer
- Squamous Cell Carcinoma

## Interventions

- **BIOLOGICAL:** Immunotherapy

## Key facts

- **NCT ID:** NCT05863052
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-01-31
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05863052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05863052, "Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05863052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*